Who Paid My Doc
Mazen Madhoun
Hospice and Palliative Medicine Salem, VA Medical Doctor
NPI 1518127927 CMS profile 662712
3737 W Main St Ste 101, Salem, VA 24153
General payments
$111
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Mazen Madhoun of Salem, VA is reported in the CMS Open Payments database as having received $111 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 50th percentile of Hospice and Palliative Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $111 | 1 |
Beside peers
- Mazen Madhoun
- Hospice and Palliative Medicine median
- Middle half of Hospice and Palliative Medicine
- National median
In program year 2025, general payments to Mazen Madhoun were reported at $0. Among 151 Hospice and Palliative Medicine profiles paid that year, the median was $79 and the middle half received between $28 and $179.
Show as a table
| Year | Mazen Madhoun | Hospice and Palliative Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $70 | $20–$164 | $163 |
| 2020 | $0 | $67 | $19–$171 | $114 |
| 2021 | $0 | $81 | $22–$170 | $132 |
| 2022 | $111 | $92 | $29–$229 | $149 |
| 2023 | $0 | $98 | $33–$185 | $160 |
| 2024 | $0 | $68 | $24–$170 | $164 |
| 2025 | $0 | $79 | $28–$179 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 403 drugsPart D claims
66,555
Drug cost
$4,602,972
Branded share of claims
22.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 2,548 | $878,645 | |
| Trulicity Dulaglutide | Brand | 355 | $203,713 | |
| Austedo Deutetrabenazine | Brand | 42 | $201,644 | |
| Ingrezza Valbenazine Tosylate | Brand | 45 | $190,513 | |
| Xifaxan Rifaximin | Brand | 107 | $148,686 | |
| Jardiance Empagliflozin | Brand | 328 | $116,615 | |
| Betaseron Interferon Beta-1b | Brand | 11 | $112,943 | |
| Ozempic Semaglutide | Brand | 85 | $87,176 | |
| Entresto Sacubitril/Valsartan | Brand | 223 | $80,406 | |
| Xarelto Rivaroxaban | Brand | 231 | $78,413 |
The 10 drugs with the highest cost, of 403 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 12 billing codesPaid by Medicare
$358,917
Medicare patients
1,208
Services billed
7,584
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Depression | 62% | |
| Arthritis | 60% | |
| Alzheimer's or dementia | 54% | |
| Diabetes | 49% | |
| Chronic kidney disease | 47% | |
| Heart failure | 46% | |
| Atrial fibrillation | 39% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hospice and Palliative Medicine in Virginia
Gregory Alouf
Hospice and Palliative Medicine · Salem, VA
Veronica Bujdos
Hospice and Palliative Medicine · Winchester, VA
Rafael Canadas
Hospice and Palliative Medicine · Arlington, VA
Rohan Oberoi
Hospice and Palliative Medicine · Alexandria, VA
Gabriella Miller
Hospice and Palliative Medicine · Chesapeake, VA
Lindsey Hunt
Hospice and Palliative Medicine · Virginia Beach, VA
Related records
Hospice and Palliative Medicine in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Hospice and Palliative Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.